Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Toren

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Harefuah|April 15, 1997
[Genetic therapy: reality and hopes]A Toren, G Rechavi
Bone Marrow Transplantation|January 7, 1998
Massive pericardial effusion complicating the course of chronic graft-versus-host disease (cGVHD) in a child with acute lymphoblastic leukemia following allogeneic bone marrow transplantationA Toren, A Nagler
British Journal of Haematology|August 1, 1994
The anti-apoptotic role of infectious agents in lymphoid malignancies characterized by c-myc deregulationA Toren, G Rechavi
Bone Marrow Transplantation|August 1, 1996
Solitary pulmonary cholesteroloma, multiple xanthelasmas and lipemia retinalis complicating hypercholesterolemia after bone marrow transplantationA Toren, A Nagler
Cytokines, Cellular & Molecular Therapy|November 24, 1998
The implications of granulocyte-monocyte colony-stimulating factor (GM-CSF) in cytotoxicity of bone marrow transplantationA Toren, A Nagler
Medical Hypotheses|December 1, 1993
What really cures in autologous bone marrow transplantation? A possible role for dimethylsulfoxideA Toren, G Rechavi
Medical Oncology (Northwood, London, England)|March 1, 1996
Curable and non-curable malignancies: lessons from paediatric cancerA Toren, N Amariglio, G Rechavi
Medical Oncology (Northwood, London, England)|October 28, 1998
Early fulminant leukaemia post autologous bone marrow transplantation in non-Hodgkin's lymphoma patientsA Toren, G Rechavi, A Nagler
Pediatric Hematology and Oncology|July 1, 1996
Pediatric cancer: environmental and genetic aspectsA Toren, G Rechavi, B Ramot
Stem Cells (Dayton, Ohio)|May 1, 1996
Minimal residual disease post-bone marrow transplantation for hemato-oncological diseasesA Toren, G Rechavi, A Nagler
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Harefuah|April 15, 1997
[Genetic therapy: reality and hopes]A Toren, G Rechavi
Bone Marrow Transplantation|January 7, 1998
Massive pericardial effusion complicating the course of chronic graft-versus-host disease (cGVHD) in a child with acute lymphoblastic leukemia following allogeneic bone marrow transplantationA Toren, A Nagler
British Journal of Haematology|August 1, 1994
The anti-apoptotic role of infectious agents in lymphoid malignancies characterized by c-myc deregulationA Toren, G Rechavi
Bone Marrow Transplantation|August 1, 1996
Solitary pulmonary cholesteroloma, multiple xanthelasmas and lipemia retinalis complicating hypercholesterolemia after bone marrow transplantationA Toren, A Nagler
Cytokines, Cellular & Molecular Therapy|November 24, 1998
The implications of granulocyte-monocyte colony-stimulating factor (GM-CSF) in cytotoxicity of bone marrow transplantationA Toren, A Nagler
Medical Hypotheses|December 1, 1993
What really cures in autologous bone marrow transplantation? A possible role for dimethylsulfoxideA Toren, G Rechavi
Medical Oncology (Northwood, London, England)|March 1, 1996
Curable and non-curable malignancies: lessons from paediatric cancerA Toren, N Amariglio, G Rechavi
Medical Oncology (Northwood, London, England)|October 28, 1998
Early fulminant leukaemia post autologous bone marrow transplantation in non-Hodgkin's lymphoma patientsA Toren, G Rechavi, A Nagler
Pediatric Hematology and Oncology|July 1, 1996
Pediatric cancer: environmental and genetic aspectsA Toren, G Rechavi, B Ramot
Stem Cells (Dayton, Ohio)|May 1, 1996
Minimal residual disease post-bone marrow transplantation for hemato-oncological diseasesA Toren, G Rechavi, A Nagler
Pageof 10